Galectin Therapeutics Inc. appointed Benjamin S. Carson, Sr., M.D. as a new member of the Board of Directors, following his service as a senior advisor to the Company since 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.24 USD | -3.28% | -7.69% | +95.18% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+95.18% | 207M | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- GALT Stock
- News Galectin Therapeutics Inc.
- Galectin Therapeutics Inc. Appoints Benjamin S. Carson as Member of the Board of Directors